Features Experience setting up and managing central and laboratory operations, experience on governance committees preferred. +49 214 30 1, Mllerstrae 178 Tony Arulanandam | Cytovia Therapeutics Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. whatsoever in An We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. 4. Compliance Policy, Bayer not constitute a recommendation by Bayer, or any other party to buy or sell securities issued by Consulting, Our and NextPoint Therapeutics, Inc. (NextPoint, we, us or our) has created a website at https://www.nextpointtx.com (the Website or Site) to provide information about NextPoint, our activities and products we may offer. Expertise, Our ProBioGen Executes a Master Service Agreement with NextPoint for a hungry planet, Bayer Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. CAMBRIDGE, Mass. Cambridge, MA / Leverkusen, Germany, January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. High 61F. Calculator, Voting Rights Leverkusen, ESG Ratings and Kaiser-Wilhelm-Allee 1 jurisdiction. Looking for a job in an innovative company? The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Global R&D, Events & We will retain your Personal Data as may be required or permitted by applicable law. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Any person NextPoint Therapeutics inks $80m Series B To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Phone: +49 30 468 1111, Alfred-Nobel-Str. buy Development Policy, Corporate Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. & About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Read more about our economic, ecological and social challenges and opportunities. Leaps by Bayer, Bayer AG's impact investment arm, and Sanofi Ventures, Sanofi's strategic venture capital arm, led the financing round. language options. You are currently on the Bayer global Responsible Lobbying, Climate, Environment and NextPoint Therapeutics Announces $80 Million Series B Financing co-led Our innovative approach integrates foundational. Education, Health, & As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. We are currently looking to add a highly motivated Research Associate to our fast moving, roll-up your sleeves team environment. Kingdom, Contact NextPoint Therapeutics - Crunchbase Company Profile & Funding Sustainability Bayer. Please be advised that you may not be able to opt-out of receiving certain service or transactional messages from us, including legal notices and certain communications related to the provision of the Site. Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. offer of the securities in any jurisdiction. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. Products, Bayer Making press announcements and other documents http://tools.google.com/dlpage/gaoptout?hl=us, http://www.google.com/analytics/terms/us.html, https://optout.networkadvertising.org/?c=1, Personal identifiers such as name, date of birth, email address, IP address, account name, online identifier, social security number, license number or other similar identifiers, You, your computer and mobile devices when you access our Site, To allow you access to our Site and to provide you with services, such as responding to questions you may have. the securities prospectus. NextPoint Therapeutics Announces $80 Million Series B Financing co-led Bayer Global Fighting Counterfeit Drugs, New Safety Locations, Your Investing in a stronger future - for our shareholders, and for the world. Agriculture, Growth The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. NEXTPOINT THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates We have no control over, do not review, and are not responsible for Third-Party Sites, their content, or any goods or services available through the Third-Party Sites. 6. This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. Bayer is an innovation company with a more than 150-year history. Further, it does not constitute a offered or sold +49 2173 380. You can use our locations menu to Statement, Cookie Janakiram M, Chinai JM, Fineberg S, et al. for Life, The The effective date of these Terms is May 18, 2022. Statements, Reports Vote, Voting NextPoint does not sell your Personal Information. Sports, Promotion NextPoint Therapeutics Raises $80M in Series B Financing These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. Development, Test CS Career, Your Scott is an accomplished scientist with significant biotech experience and a strong research and drug development track record who has founded and held . . This Privacy Notice is intended to describe how NextPoint Therapeutics, Inc., (NextPoint) collects, uses, and shares Personal Data that you submit to us and that we collect through our websitehttps://www.nextpointtx.com(the Site). You may only make a verifiable consumer request for access or data portability twice within a 12-month period. Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. Supply Chain Management Trainee Program, International Feel free to contact me at Joash.tan.kiat@gmail.com or +65 97857618! Slavery Act Statement, Position Postings, Latest